PathAI

Today, we announced the launch of our latest #AIPathology tool, PathExplore™ Fibrosis- an AI-driven breakthrough that brings powerful #fibrosis, collagen, and fiber quantification directly from your standard H&E whole-slide images. See it in action: https://lnkd.in/evxurVfg In #cancerresearch, fibrosis and collagen fibers are increasingly recognized as critical biomarkers linked to disease progression, immune response, and treatment outcomes. Traditional methods for quantifying these features often rely on labor-intensive techniques that are difficult to scale. PathExplore™ Fibrosis changes that. Powered by #AI, it seamlessly integrates into routine pathology workflows—no special stains, no extra equipment—just precise, scalable analysis directly from your H&E slides. - Effortlessly Scalable: Perform rapid, large-scale fibrosis and collagen analysis, speeding up biomarker discovery and research timelines. - Deep Tumor Insights with Deep Learning: Quantify fibrotic features with precision, offering a clearer understanding of tumor biology and therapeutic impact. - Optimized for your routine H&E Samples: Easily integrate into your existing processes without the need for complex microscopy or custom staining techniques. PathExplore™ Fibrosis is for research use only. Not for use in diagnostic procedures. #Pathology #biotech #digitalpathology #oncology

🚀 We're proud to launch PathExplore™ Fibrosis, a groundbreaking #AIPathology algorithm that quantifies fibrosis, collagen, and fiber morphology directly from H&E whole-slide images. This revolutionary tool provides a unique view into the tumor microenvironment (#TME), empowering researchers & drug developers to better understand the #fibroticmicroenvironment to unlock key insights for #cancer progression and therapeutic response. 📝 Read the full announcement: https://lnkd.in/eChYqq3j Fibrosis and collagen fibers are emerging #biomarkers in #cancerresearch, linked to disease progression, immune response, and treatment outcomes. Today, their quantification often relies on specialized staining methods or specialized #microscopy techniques. These methods can be time-consuming, labor-intensive, and difficult to scale for large studies. By combining the power of AI with standard #pathology workflows, PathExplore™ Fibrosis is democratizing access to these crucial biomarkers directly from H&E whole slide images. 𝐅𝐚𝐬𝐭 & 𝐒𝐜𝐚𝐥𝐚𝐛𝐥𝐞 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬: Unlike traditional methods that require special stains, complex imaging technology, and additional tissue, PathExplore™ Fibrosis leverages AI to quickly analyze routine H&E-stained slides, enabling large-scale studies and fast #biomarkerdiscovery. 𝐐𝐮𝐚𝐧𝐭𝐢𝐭𝐚𝐭𝐢𝐯𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬: The measurement of fibrosis, collagen, and fiber morphology directly from whole-slide images provides an unprecedented level of detail on #tumormicroenvironment features, offering new opportunities to explore tumor biology and therapeutic responses. 𝐈𝐧𝐭𝐞𝐠𝐫𝐚𝐭𝐞 𝐰𝐢𝐭𝐡 𝐒𝐭𝐚𝐧𝐝𝐚𝐫𝐝 𝐏𝐚𝐭𝐡𝐨𝐥𝐨𝐠𝐲 𝐖𝐨𝐫𝐤𝐟𝐥𝐨𝐰𝐬: By working with standard pathology workflows (H&E-stained slides), the algorithm democratizes advanced fibrosis analysis, allowing labs to integrate it easily without additional microscopy equipment or complex preparation techniques. PathExplore™ Fibrosis is for research use only. Not for use in diagnostic procedures

Earlier today our Chief Medical Officer, Eric Walk MD, FCAP participated in the panel 'Advancing Digital and #AIPathology in #PrecisionMedicine: Where Are We Now?' at the Advancing Precision Medicine #APM24 conference in Philadelphia. The panel discussed the rising adoption of digital solutions in pathology and the emergence of new technologies that are driving #biomarker discovery and accelerating algorithm development. #Partnerships remain critical to overcoming barriers for #digitalpathology adoption. #advancingprecisionmedicine #ai #health #cancer #oncology #pathology

📣 PathAI is hiring! Our team is passionate about finding creative solutions in #healthtech to transform the field of #pathology with #artificialintelligence. We are looking for new team members to join us on our mission to improve patient outcomes and fuel #biopharma research 🔬 Our core values: 𝐏atients First We embody a patient-first mindset in everything we do and are committed to meeting the needs of our customers to improve patient outcomes. 𝐀ccountability We set out to accomplish the tasks we commit to and take responsibility for our work, and our actions. 𝐓eam We are One PathAI, all working towards the same goal. We trust our teammates and count on each other to get the job done. 𝐇umility We know all that we do matters, big and small. We value openness, we are accepting of others, and are curious to learn from each other. 𝐀ll 𝐈n We are all passionate about our mission and our passion pushes us to be better every day. Apply today: https://lnkd.in/e8GArtha #opentowork #hiring #leadership #regulatory #regulatoryaffairs #biopharma #biotechsales #biotech #biotechnology #newpositions

🎃 Happy #Halloween from your partners at PathAI! 🎃

Today, we’re proud to announce that Vizia Diagnostics, a GI- specialized #pathology laboratory based in Alpharetta, Georgia, has announced that VIZIA has adopted PathAI’s AISightⓇ Image Management System (IMS) and #AI technology to advance the precision and operational efficiency of its pathology services. 🔗 Discover how PathAI’s #digitaldiagnostics solutions can transform pathology labs in our latest #pressrelease: https://lnkd.in/eRdmMGSH In today’s rapidly evolving pathology landscape, independent labs face increasing pressure to provide timely and accurate assessments. To meet these demands, VIZIA Diagnostics conducted a thorough evaluation of #digitalpathology solutions and selected PathAI’s AISight Image Management System as the ideal platform. AISight’s robust workflow optimization, advanced case management, and broad applicability across various use cases were key factors in the decision. By integrating AISight with algorithm products, VIZIA Diagnostics aims to improve turnaround times for their clients and deliver even higher-quality pathology services. "AISight offers more than just efficiency; it empowers us to lead in the evolving field of #gastrointestinal pathology," said Gregg Costantino, CEO of VIZIA Diagnostics. "By streamlining our workflows and enhancing accuracy, we're able to deliver faster, more precise results for our clients. This collaboration aligns with our commitment to being a flexible and quality-focused partner, providing exceptional service and care in the GI space, and positioning us at the forefront of digital and AI pathology." "The transformative potential of AI and Digital Pathology, coupled with the growing need for business-critical solutions our pathologists and GI providers require, was at the forefront of our decision to adopt this system," added Ed Cochrane, Commercial Director of VIZIA Diagnostics. “PathAI’s platform provides us with unmatched agility and responsiveness for the dynamic landscape of anatomic pathology and our diverse customer base.” #PathAI #AISight #partnership #AIPathology #biotech #biotechpartnership #biotechnologynews #biotechnews AISight is for research use only. Not for use in diagnostic procedures.

PathAI CEO, Andrew Beck is live at the Inaugural #CancerAISymposium hosted by Google Cloud presenting "Transforming Oncology #DrugDevelopment with #AI-Powered Digital #Pathology." Learn more about Andy and our mission to improve patient lives with #AIPathology: https://lnkd.in/eR8dWEWu #digitalpathology #Cancer #Oncology

Attending #PathVisions2024? Stop by PathAI’s booth #412 to discover how AISight IMS empowers labs with advanced digital and AI-powered tools. Learn how AISight streamlines case management and optimizes pathology workflows, ensuring your lab stays efficient and ahead of the curve. 📅 Schedule your demo today: https://lnkd.in/eh7-atXg #PathVisions #pathai #digitalpathology #aipathology #aihealthcare #anatomicpathology AISight is for research use only. Not for use in diagnostic procedures.

PathAI is live at the #ORIEN Scientific Summit in Tampa, FL! Stop by our table to meet Ryan Leung and learn more about his presentation “Advancing #PrecisionMedicine with AI-Powered #Pathology” & the utilization of #histopathology #RealWorldData Learn more about PathExplore™ and #RWD by visiting our website: https://lnkd.in/ehU9Begy 🤝 Book a meeting with us: https://lnkd.in/eTVsBzUN PathExplore™ is for research use only. Not for use in diagnostic procedures. #oncology #AI #biotech #healthtech

🌐 In the latest edition of Discussion with the Scientists, we sat down with Ryan Leung, Head of Biopharma Oncology Product & Strategy at PathAI, to discuss how AI-powered #pathology is transforming #RealWorldData into actionable insights for #PrecisionMedicine and #CancerResearch. Ryan explains how combining histopathology with other #RWD sources offers potential opportunities to improve patient outcomes and accelerate #drugdevelopment. Read the Q+A to learn about the utility of #oncology real-world data! #Healthtech #DigitalPathology #OncologyRWD #AI